Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
Midas Letter RAW is the irreverent, intelligent show about investing for the little guy. Ed Milewski, former stock broker and reformed accountant brings his cynical and off-beat chart observations int... more
FAQs about Midas Letter:How many episodes does Midas Letter have?The podcast currently has 1,015 episodes available.
October 19, 2021Cybin (CYBN) Growing IP Supports Faster & Shorter Psychedelic TreatmentsCybin Inc (NEO:CYBN, NYSEAMERICAN:CYBN) is a drug development company with four active psychedelic clinical programs targeting Major Depressive Disorder, Alcohol Use Disorder and Therapy Resistant Psychiatric Disorders (CYB001, CYB003, CYB004, CYB005). But, it’s not just four molecules the company is testing, Cybin has […]...more0minPlay
October 18, 2021Compelling Low-Cost, Large-Scale Global Cannabis Opportunity | Clever Leaves (CLVR)Clever Leaves Holdings Inc (NASDAQ:CLVR) is a global cannabis company with large-scale, low-cost cultivation and pharmaceutical-grade cannabinoid processing in the United States, Canada, Colombia, Germany and Portugal. CLVR has been publicly trading for almost 12 months now and has proven its ambitions […]...more0minPlay
October 14, 2021What to Watch Out For When Investing | Midas Letter RAW ft DELC, CYBN, CLVRFirst and foremost, Midas Letter wants to thank all of our watchers as our YouTube audience surpasses 30,000 subscribers. We wouldn’t have a show without you, and our gratification can not fully be expressed and only be shown by us continuing to […]...more0minPlay
October 13, 2021Whats Driving Psychedelic Stock Mydecine (MYCO, MYCOF) $3 Analyst Target?Mydecine Innovations Group Inc (NEO:MYCO, OTCMKTS:MYCOF) is an emerging biotech company dedicated to developing treatments for mental health problems. The company’s medical and scientific advisory board is building out a pipeline of psychedelic-assisted therapeutics and a variety of novel compounds. Mydecine’s primary […]...more0minPlay
October 11, 2021Award-Winning CBD Company with Top 5 Global Player Ambitions | Sweet Earth Holdings (SE)Sweet Earth Holdings Corp (CNSX:SE, OTCMKTS:SEHCF) operates in the cannabidiol (CBD) market with a large focus on the research & development and bioavailability of the chemical founds in cannabis. The company already has CBD distribution across Canada, the US, South America, Europe […]...more0minPlay
October 08, 2021What Stocks are Running for Ed’s Homecoming? | Midas Letter RAW ft MYCO, SE, CWRKThe market has taken a tumble since Ed was away, but he’s back now and here to stay. Crypto is still climbing to our dismay, but please be careful; we don’t want you to pay! We will look through many commodity charts […]...more0minPlay
October 05, 2021Voxtur Analytics (VXTR) Expands Platform with Asset Management AcquisitionVoxtur Analytics Corp (OTCMKTS:VXTRF, CVE:VXTR) made another tech-centric acquisition expanding its vast real estate product portfolio. On top of providing services in property tax, valuations, and title services, Voxtur’s acquisition of RealWealth (to be renamed VoxturWealth) expands the platform to meet the […]...more0minPlay
October 04, 2021New Tech Reducing GHG Emissions & Organic Waste Up to 90% | CHAR Technologies (YES)CHAR Technologies Ltd (CVE:YES, OTCMKTS:CTRNF) is a cleantech company specializing in converting woody materials and organic waste into renewable gases and biocarbon. There is a lot of excitement in the company’s conversion process. A process called High-Temperature Pyrolysis (HTP). This proprietary technology reduces […]...more0minPlay
October 01, 2021US Not Banning Crypto, Is This Your Buying Window? | Midas Letter RAW ft Voxtur (VXTR)Today, Bitcoin (BTC) and cryptocurrencies surged after Federal Reserve Chairman Jerome Powell announced the U.S. doesn’t have plans to ban cryptocurrencies. This happens after China’s sweeping cryptocurrency ban causing the price of Bitcoin and the like to plummet. The two largest global […]...more0minPlay
September 30, 2021Maximizing Public Benefit of Psychedelics | MAPS PBCThe public reputation of pharmaceutical companies is far from positive. The priorities of a public pharma company is to make money for shareholders and not necessarily put the needs of patients first. The creation of a public benefit corporation (PBC) enables biotech’s […]...more0minPlay
FAQs about Midas Letter:How many episodes does Midas Letter have?The podcast currently has 1,015 episodes available.